US2012143338A1PendingUtilityA1
Replacement or supplementation of a nucleus pulposus using a hydrogel
Est. expiryMay 21, 2024(expired)· nominal 20-yr term from priority
A61L 27/52A61L 27/00A61F 2/44A61F 2002/30242A61F 2002/3008A61F 2002/4627A61B 17/3472A61F 2002/4495A61F 2/4611A61F 2002/444A61F 2/442A61F 2230/0071A61F 2250/0098A61B 17/3468
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A nucleus pulposus of an intervertebral disc is supplemented or replaced by a physiologically fully hydrated solid hydrogel intervertebral body comprising a polyvinyl alcohol copolymer, wherein the solid hydrogel intervertebral body exhibits an osmotic pressure of from 0.1 to 0.3 megapascals prior to insertion into a patient, the solid hydrogel intervertebral body having a ratio of length to principal transverse dimension not less than about 5:1.
Claims
exact text as granted — not AI-modified1 . A physiologically fully hydrated solid hydrogel intervertebral body comprising:
a polyvinyl alcohol copolymer, wherein the solid hydrogel intervertebral body exhibits an osmotic pressure of from 0.1 to 0.3 megapascals prior to insertion into a patient, and wherein the solid hydrogel intervertebral body has a ratio of length to principal transverse dimension not less than about 5:1.
2 . The solid hydrogel intervertebral body of claim 1 , wherein the body has a ratio of length to principal transverse dimension of about 350:1.
3 . The solid hydrogel intervertebral body of claim 1 , wherein the body has an elastic modulus between about 0.05 megapascals and about 4.0 megapascals.
4 . The solid hydrogel intervertebral body of claim 1 , wherein the body has a generally cylindrical shape.
5 . The solid hydrogel intervertebral body of claim 1 , wherein the body has at least one portion with a cross-sectional area greater than a principal cross-sectional area of said body.
5 . The solid hydrogel intervertebral body of claim 1 , wherein the body has at least one end provided with a terminal portion of transverse cross-sectional area greater than a principal cross-sectional area of said body.
6 . The solid hydrogel intervertebral body of claim 1 , wherein the body has at least one end provided with a flared terminal portion of transverse cross-sectional area greater than a principal cross-sectional area of said body.
7 . The solid hydrogel intervertebral body of claim 1 , wherein the body has at least one end provided with a generally spherical terminal portion of transverse cross-sectional area greater than a principal cross-sectional area of said body.
8 . The solid hydrogel intervertebral body of claim 1 , wherein the body has at least one portion between its ends with a transverse cross-sectional area greater than a principal cross-sectional area of said body.
9 . The solid hydrogel intervertebral body of claim 1 , wherein the body further comprises poly(vinylpyrrolidone).
10 . The solid hydrogel intervertebral body of claim 1 , wherein the body comprises a radiopaque material.
11 . The solid hydrogel intervertebral body of claim 10 , wherein the radiopaque material is barium sulfate.
12 . The solid hydrogel intervertebral body of claim 1 , wherein the body has a ratio of length to principal transverse dimension of about 40:1.
13 . The solid hydrogel intervertebral body of claim 1 , wherein the body has a ratio of length to principal transverse dimension of about 100:1.
14 . The solid hydrogel intervertebral body of claim 1 , wherein the body has a ratio of length to principal transverse dimension of about 200:1.
15 . The solid hydrogel intervertebral body of claim 1 , wherein the body has a generally cylindrical shape.
16 . A physiologically fully hydrated solid hydrogel intervertebral body comprising a polyvinyl alcohol copolymer, wherein the fully hydrated solid hydrogel intervertebral body is made by a process comprising the step of:
contacting a hydrogel body comprising a polyvinyl alcohol copolymer with an aqueous isotonic solution for a period of time sufficient to achieve physiological full hydration, wherein the solid hydrogel intervertebral body exhibits an osmotic pressure of from 0.1 to 0.3 megapascals prior to insertion into a patient, and wherein the solid hydrogel intervertebral body has a ratio of length to principal transverse dimension not less than about 5:1.
17 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the contacting step comprises immersing the hydrogel body in the aqueous isotonic solution.
18 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the aqueous isotonic solution has an osmotic pressure of about 0.2 megapascals.
19 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the aqueous isotonic solution further comprises a polymer.
20 . The fully hydrated solid hydrogel intervertebral body of claim 19 , wherein the polymer is selected from the group consisting of poly(ethylene glycol), dextran, and mixtures thereof.
21 . The fully hydrated solid hydrogel intervertebral body of claim 20 , wherein the polymer is dextran.
22 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the body has a ratio of length to principal transverse dimension of about 350:1.
23 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the body has an elastic modulus between about 0.05 megapascals and about 4.0 megapascals.
24 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the body has a generally cylindrical shape.
25 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the body further comprises poly(vinylpyrrolidone).
26 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the body comprises a radiopaque material.
27 . The fully hydrated solid hydrogel intervertebral body of claim 26 , wherein the radiopaque material is barium sulfate.
28 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the body has a ratio of length to principal transverse dimension of about 40:1.
29 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the body has a ratio of length to principal transverse dimension of about 100:1.
30 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the body has a ratio of length to principal transverse dimension of about 200:1.
31 . The fully hydrated solid hydrogel intervertebral body of claim 16 , wherein the body is isotonic with respect to surrounding physiological fluid prior to implantation within the physiological fluid.Join the waitlist — get patent alerts
Track US2012143338A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.